Overall ALL cases show lower CEBPA transcript levels, this seems to sustain the hypothesis that both a reduction and increase in gene dosage may be involved in the pathogenesis of various leukemia types. The gene discussed is CEBPA; the disease is acute lymphoblastic leukemia.